ArticlePharmacoEconomics2014

Pharmacoeconomic evaluation of dabigatran, rivaroxaban and apixaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement in Spain.

Antonio Gómez-Outes et al.PubMed ↗Publisher ↗

No numbers read from the abstract.